This trial is evaluating whether Community DUP Assessment Tool will improve 9 primary outcomes and 2 secondary outcomes in patients with Psychotic Disorders. Measurement will happen over the course of end of study, maximum of 5 years.
This trial requires 1329 total participants across 2 different treatment groups
This trial involves 2 different treatments. Community DUP Assessment Tool is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"There may be difficulty concentrating, sleeping problems and sadness. There may be other signs of mental disorders that are not recognised as being associated with mental disorders, for example, difficulty making friends, having trouble concentrating and forgetting things. The most noticeable symptoms in a mental disorder are the symptoms which affect the most functioning aspects of a person's life, and the symptoms experienced more often than those who do not have a mental disorder.\n" - Anonymous Online Contributor
"Approximately 2.5 million Americans are admitted to a hospital every year, and 1.2 million of these see one or more hospitalizations. About 1 in 45 Americans suffers from a psychiatric illness each year. For comparison, approximately 25% of the male and 6% of the female American population suffers from a mental disorder in a given year." - Anonymous Online Contributor
"Mental disorders are likely to be caused by a combination of factors including genetics, damage to the nervous system by viruses, and the effects of hormones, such as the neurosteroids in childhood and the stress of early puberty.\n" - Anonymous Online Contributor
"It is essential that the mental health professionals of each case must be aware of the different treatment approaches, so that they do not fail to diagnose or treat patients when such different approaches should not be taken." - Anonymous Online Contributor
"The term'mental disorders' is too narrow and not inclusive enough. We recommend a more inclusive, more global approach in the field. For example, mental disorders are a part of general medicine and need to be treated from a holistic perspective. We need to start with a more comprehensive view of the mental and physical health of the affected and care personnel and then move on from there for the next step. We emphasize the urgent need for a global consensus in our field. The term'mental disorders' has to give way to terms like'mental illness' and'mental illnesses'." - Anonymous Online Contributor
"The presence of an underlying mental disorder does not seem to affect the long-term prognosis of schizophrenia. However, major depression appears to improve survival of long-term patients, whereas substance abuse causes an increased risk of mortality from suicide or drug overdose." - Anonymous Online Contributor
"Mental disorder is prevalent among the family members of patients with mental health disorders and vice versa, suggesting an important biological factor. Additional research into the genetic etiology of mental disorders is important; however, the current results highlight the potential value of family-level assessment and interventions in identifying individuals at risk for mental disorders, potentially leading to a more individualized treatment paradigm." - Anonymous Online Contributor
"In a recent study, findings revealed that the average age of first onset of depressive disorders is 24.5, and for first onset of obsessive compulsive disorders is 26.2. The age of onset of first onset of anxiety disorders is 27.6 for men and 25.3 for women." - Anonymous Online Contributor
"The causal factors listed above are the result of studying specific subgroups, that they should not be called primary causes, since the problem of causality is a complex one; and that the causality-factor analysis is not yet perfect (a single factor is never the whole cause, and there is usually an infinite number of causes).\n\n- List of psychiatric drugs\n\n- Drugs." - Anonymous Online Contributor
"Given the limitations of the available studies (a small number of studies and a limited number of instruments), the data from these studies imply that the DAT does not work very well. The conclusions from this review highlight the need for further research that focuses on more rigorous research design." - Anonymous Online Contributor
"Clinicians in Canada who want to trial medications for patients have the choice of two types of clinical trials to take part in, but should also consider the opportunity to take part in a research trial. Since clinicians often rely on available knowledge and opinions about the benefits of taking part in clinical research to make treatment decisions, they should strive to get good news reports about promising treatments for patients." - Anonymous Online Contributor
"Results from a recent clinical trial of this study show the potential of the CDAT in the clinical management of patients with mental disorders. The CDAT can provide an accurate guide to a professional to know which treatment to provide, with or without a specific type of medication in combination with community management. The CDAT is not only useful to the clinician but equally important to the patient and his / her family for self-esteem, and acceptance with their mental disorder and their own personality. The CDAT can increase awareness, confidence, and willingness of the patients to receive treatment, thus improving the quality of care provided to them and therefore reduce the incidence of relapse, reduce hospital admissions for medical treatment, and/or reduce the cost of treatment." - Anonymous Online Contributor